PharmSource - CMO Scorecard: Outsourcing of NDA Approvals and CMO Performance - 2018 Edition
Summary
This report is the 8th edition of our long running analysis of the CMO Industry, using NDA approvals as the primary indicator of performance. CMO Scorecard is critical for benchmarking the performance of the CMO industry and the relative performance of major CMOs.
Reasons to buy
This 43-page report gives important, expert insight you won’t find in any other source. 28 tables and figures throu
Read More
- List of Tables
- Table 1: Outsourced NDA Approvals by Dosage Form 12
- Table 2: Outsourcing by Sponsor Type and FDA Approval Type 2012-2017 13
- Table 3: API CMOs Receiving NME Approvals in 2017 23
- Table 4: 2017 CBER Approvals Included in the Analysis 27
- Table 5: 2017 Outsourced Dose Approvals 27
- Table 6: Dose CMOs Receiving Contracts for FDA Approvals in 2008-2017 31
- Table 7: 2017 Outsourced API Approvals 35
- Table 8: Dose CMOs Manufacturing NDAs Approved 2017 39
- Table 9: MHRA Approvals in 2017 42
Read More
- Table of Contents
- 1. Executive Summary 5
- 2. Introduction 6
- 3. NDA Approvals Overview 6
- 4. US Versus EU Approval Performance 8
- 5. Outsourced Dose Manufacture 9
- 6. Special Product Categories 13
- 7. Outsourcing by Global Bio/Pharma Companies 17
- 8. CMO Performance 19
- 9. Outsourced API Approvals 21
- 10. What It Means 24
- 11. Notes on Methodology 25
- 12. Appendix 27
Read More